Johnson & Johnson (JNJ) Notes Payables (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Notes Payables data on file, last reported at $17.5 billion in Q1 2026.

• Quarterly Notes Payables rose 25.64% year-over-year to $17.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.5 billion (up 25.64% YoY) and the FY2025 annual result came in at $8.5 billion, up 41.99% from the prior year.
• Notes Payables grew to $17.5 billion in Q1 2026 per JNJ's latest filing, from $8.5 billion in the prior quarter.
• The five-year high for Notes Payables was $18.0 billion in Q2 2023, with the low at $3.5 billion in Q4 2023.
• Average Notes Payables over 5 years is $8.5 billion, with a median of $7.4 billion recorded in 2025.
• The widest YoY moves for Notes Payables: up 318.41% in 2023, down 72.95% in 2023.
• Johnson & Johnson's Notes Payables stood at $4.4 billion in 2022, then dropped by 21.99% to $3.5 billion in 2023, then surged by 73.37% to $6.0 billion in 2024, then jumped by 41.99% to $8.5 billion in 2025, then jumped by 105.53% to $17.5 billion in 2026.
• Business Quant data shows JNJ's Notes Payables at $17.5 billion in Q1 2026, $8.5 billion in Q4 2025, and $6.4 billion in Q3 2025.